Hemogenyx Pharmaceuticals Plc (HEMO.L) LSE
Currency In GBp
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 25.41M |
| Enterprise Value | 25.83M |
| P/E Ratio | -3.67 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 40.94 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -8.7 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -2.34 |
| Return On Equity | -28.08 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -588,753 |
| EBITDA | -4.07M |
| Net Income | -9.76M |
| Diluted EPS | -2.2 |
Balance Sheet
| Total Cash | 1.59M |
| Total Cash/Share | 0.26 |
| Total Debt | 2M |
| Total Debt/Equity | 1.68 |
| Current Ratio | 1.38 |
| Book Value Per Share | 0.19 |
Price History
| 52-Week Change | 377.17 |
| 52-Week High | 1,800 |
| 52-Week Low | 124 |
| Moving Average 50 Days | 743.29 |
| Moving Average 200 Days | 855.87 |
Statistics
| Average Volume | 22,648 |
| Shares Outstanding | 6.8M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:400 |
| Last Split Date | December 13, 2024 |
AD
